27 July 2010, 5:30 am
BOTHELL, WA--(Marketwire - 07/27/10) - Marina Biotech, Inc. (NASDAQ: MRNAD - News ) (formerly known as MDRNA, Inc.) and Dr. Pirjo Laakkonen at the University of Helsinki Biomedicum in Finland today announced the extension of their collaboration to identify novel peptides with preferential homing-like properties which allow the peptides to target specific tissues, including tumors. The ...... Read More »